drugset / Trial / NCT07152886
The Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer
Phase 4
Not yet recruiting
238 enrolled
The Affiliated Hospital of Qingdao University
Dongying People's Hospital · collabJining First People's Hospital · collabLinyi People's Hospital · collabQianfoshan Hospital · collabQilu Hospital of Shandong University · collabRizhao People's Hospital · collabShandong Cancer Hospital and Institute · collabShandong Provincial Hospital · collabTaian City Central Hospital · collabThe Affiliated Hospital of Shandong Second Medical University · collabWeifang People's Hospital · collabYantai Yuhuangding Hospital · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study is a multicenter randomized controlled trial designed to investigate the effects of Clostridium butyricum on adverse events during adjuvant treatment for colorectal cancer.
Timeline
- Start
- 2025-10-31
- Primary completion
- 2027-10-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clostridium butyricum | Other / unclassified | 6 unknown | Oral |